Gregg Gilbert

Stock Analyst at Truist Securities

(2.28)
# 2,568
Out of 4,711 analysts
91
Total ratings
53.7%
Success rate
5.14%
Average return

Stocks Rated by Gregg Gilbert

DHT Holdings
Feb 16, 2024
Maintains: Buy
Price Target: $14$17
Current: $8.95
Upside: +89.94%
Collegium Pharmaceutical
Jan 4, 2024
Maintains: Buy
Price Target: $31$37
Current: $29.70
Upside: +24.58%
Bristol-Myers Squibb Company
Sep 15, 2023
Reiterates: Buy
Price Target: $84
Current: $57.33
Upside: +46.52%
Eli Lilly
Jul 20, 2023
Maintains: Buy
Price Target: $430$525
Current: $767.76
Upside: -31.62%
Evolus
Mar 4, 2022
Maintains: Buy
Price Target: $11$13
Current: $10.89
Upside: +19.38%
NovoCure
Jan 20, 2022
Upgrades: Buy
Price Target: n/a
Current: $30.80
Upside: -
Merck & Co.
Jun 7, 2021
Maintains: Buy
Price Target: $96$93
Current: $98.05
Upside: -5.15%
Arcutis Biotherapeutics
Feb 2, 2021
Maintains: Buy
Price Target: $38$48
Current: $14.99
Upside: +220.21%
Coherus BioSciences
Apr 17, 2020
Initiates: Buy
Price Target: $26
Current: $1.52
Upside: +1,610.53%
Matinas BioPharma Holdings
Jan 24, 2020
Initiates: Buy
Price Target: $150
Current: $0.55
Upside: +27,422.93%
Downgrades: Hold
Price Target: $93$78
Current: $25.75
Upside: +202.91%
Maintains: Hold
Price Target: $76$78
Current: $164.84
Upside: -52.68%
Maintains: Hold
Price Target: $20$18
Current: $22.09
Upside: -18.52%
Downgrades: Sell
Price Target: n/a
Current: $114.64
Upside: -
Maintains: Buy
Price Target: $178$175
Current: $122.97
Upside: +42.31%
Maintains: Hold
Price Target: $65$66
Current: $175.58
Upside: -62.41%